Overview
Nonprofit managed care organization improving health and well-being.
Founded
1989
Deals ยท 12mo
1
Stage focus
Geographic focus
Sector focus
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Radley Health | Jun 2026Participated | $3 MSeed | |
myBiometry | Nov 2024Participated | $5 MSeed | |
Your Money Line | Aug 2024Participated | $5 MSeries A | |
Tuesday Health | May 2024Participated | $60 MOther Equity | |
Augment Therapy | May 2023Led | $1 MOther Equity | |
Wayspring | Sep 2021Participated | $75 MOther Equity | |
axialHealthcare | Sep 2021Participated | $75 MOther Equity | |
Radley Health | Jun 2026Participated | $3 MSeed | |
myBiometry | Nov 2024Participated | $5 MSeed | |
Your Money Line | Aug 2024Participated | $5 MSeries A | |
Tuesday Health | May 2024Participated | $60 MOther Equity | |
Augment Therapy | May 2023Led | $1 MOther Equity | |
Wayspring | Sep 2021Participated | $75 MOther Equity | |
axialHealthcare | Sep 2021Participated | $75 MOther Equity |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 0 | 2 |
| Series A | 0 | 1 |
| Other Equity | 1 | 3 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Sep '21 | 2 |
| Oct '21 | 0 |
| Nov '21 | 0 |
| Dec '21 | 0 |
| Jan '22 | 0 |
| Feb '22 | 0 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 0 |
| Jul '22 | 0 |
| Aug '22 | 0 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 1 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 0 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 1 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 1 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 1 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 0 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 1 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 5 |
| Professional Services | 2 |
| Data, Analytics & IT | 2 |
| Government & Defense | 1 |
| Fintech | 1 |
| AI & Machine Learning | 1 |
| Developer Tools | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 3 |
| $5M-$10M | 1 |
| $10M-$25M | 0 |
| $25M-$50M | 0 |
| $50M-$100M | 3 |
| $100M-$250M | 0 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 1 of 1 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 7 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| BlueCross BlueShield Venture Partners | 3 |
| Valtruis | 3 |
| .406 Ventures | 2 |
| Centene Corporation | 2 |
| Elevate Ventures | 2 |
| Highmark Ventures | 2 |
| HLM Venture Partners | 2 |
| Oak HC/FT | 2 |
| Allos Ventures | 1 |
| Aurora Forge | 1 |
| Dexcom Ventures | 1 |
| First Trust Capital Partners | 1 |
| Jackson Healthcare | 1 |
| Mass General Brigham Ventures | 1 |
| Peg's Foundation | 1 |
| Sandbox Industries | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 1 | 14% |
| Participating | 6 | 86% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 1 | 100% |
| Co-led | 0 | 0% |
Team
Executive Director of Child Welfare
Associate Vice President, Federal Compliance
Chief Information Officer
General Counsel & Senior Vice President of Legal
Technology Architect
Senior Vice President, Specialty Companies and Complex Health Solutions
Vice President, Pharmacy Innovation
Director, Business Development